PATH’s board of directors believes that Steve’s experience, leadership, and strategic vision will continue the organization’s long tradition of collaboration in achieving advances in global health.”. Steve Davis (1929-1987), également connu sous son nom musulman de Luquman Abdul Syeed, était un bassiste de jazz très actif dans les années 1960. PATH Audit Committee Chair; Founder and Managing Director, Continuum Advantage / Ghana and United States, President, Moccasin Lake Foundation / United States, PATH Board Vice Chair; Senior Vice President of Worldwide Human Resources, Amazon / United States, Partner, portfolio manager, co-head of alternative credit at Ares Management Corporation / United States, PATH Board Chair; Operating Partner, Pritzker Private Capital / United States, PATH Board Treasurer and Finance Committee Chair; President of The Builders Initiative / United States, PATH Development Committee Chair; Principal, Melzer Healthcare Advisors / United States, Founder of CameoWorks, LLC / United States, Chief Executive of the Research Council of Norway / Norway, Founder and Managing Director, Tillit MSME Microservices / Nigeria, PATH Governance Committee Chair; Founder of A Bird’s Eye View Ltd / United Kingdom, PATH Board Secretary; CEO of Luye Pharmaceutical Group (International) / China and United States, Senior Vice President of Public Health, and Chief Medical and Public Health Officer, Chief of Business, Finance and Operations and Interim Chief of the Asia/Middle East/Europe Region, Vice President, Essential Medicines Director, Director, East Africa Hub and Kenya Country Program, Global Head of Policy, Access, and Introduction, PATH Center for Vaccine Innovation and Access, Program Leader, Malaria Vaccine Initiative Leader, Malaria Disease Area, PATH Center for Vaccine Innovation and Access, Global Head, Chemistry, Manufacturing, Control and Nonclinical Toxicology, Chief Scientific Officer & Program Co-Lead, Diagnostics, Leader, Enteric and Diarrheal Diseases, PATH Center for Vaccine Innovation and Access, Program Leader, Maternal, Newborn, and Child Health and Nutrition, Global Head, Clinical, PATH Center for Vaccine Innovation and Access, Senior Director of Financial Planning and Analysis, Director, Global Facilities, Travel, and Security, Country Director, the Democratic Republic of the Congo, Director of US and Global Policy and Advocacy, Leader, Respiratory Infections and Maternal Immunizations, PATH Center for Vaccine Innovation and Access, Leader, Integrated Portfolio and Financial Management, PATH Center for Vaccine Innovation and Access, Managing Director, PATH's Center for Vaccine Innovation and Access, and Director, Office of Essential Medicines, Vice President of Accounting and Financial Operations, Managing Director, Programs and Innovation Division, Senior Director, Partnerships Development, Director of Monitoring, Evaluation, and Learning, Director of Operations & Program Co-Lead, Diagnostics, Chief Digital Officer; Director, Center of Digital and Data Excellence (CoDE), Program leader, Malaria and Neglected Tropical Diseases; Director, Center for Malaria Control and Elimination, Global Head, Essential Medicines Quality Unit, Senior Director, Technical Strategy & Program Quality, Global Head, Regulatory, PATH Center for Vaccine Innovation and Access, Program Leader, Medical Devices and Health Technologies. Davis has led the Seattle nonprofit health organization with more than 1,500 employees for more than seven years. PATH Board Treasurer and Finance Committee Chair; President of The Builders Initiative / United States. This site uses cookies to collect activity data and personalize content. Deanna Oppenheimer. Under Mr. Davis’s leadership, PATH will continue to develop innovative health solutions that have a deep impact on communities in the developing world. By continuing to navigate this site, you agree to allow us to collect information using cookies. “I have long admired PATH for its spirit of innovation and its tremendous strides in addressing inequities and saving lives around the world,” said Mr. Davis. Sanford M. Melzer, MD, MBA. Founder of CameoWorks, LLC / United States. Steve Davis is a lecturer at the Stanford Graduate School of Business. Mr. Davis earned his bachelor’s degree from Princeton University, his master’s degree from the University of Washington, and his juris doctor from Columbia University. Mr. Davis will oversee an annual budget of $305 million, a staff of nearly 1,200, and a robust portfolio of projects based in PATH offices in 22 countries. Category News & Politics Mr. Davis brings leadership experience in numerous innovation-focused organizations, both nonprofit and for-profit, and has worked extensively in emerging economies throughout his career. Learn more about how we care for your data in our privacy notice. Learn more about how we care for your data in our privacy notice. The organization has reached an estimated 45 million direct and indirect beneficiaries in the past year with an affordable meningitis vaccine, improved screening and treatment for HIV/AIDS and tuberculosis, affordable filters for safe drinking water, and other low-cost, high-impact solutions. “Steve brings a history with PATH as a previous board member and is a proven innovator and versatile leader with a longstanding commitment to social change. His previous experiences also include serving as interim director of PATH’s India program, practicing law with K&L Gates, and working on refugee and human rights issues. Seattle, March 26, 2012—PATH announced today that Steve Davis has been appointed president and CEO. Proven leader has a distinguished business career and longstanding commitment to global health. Photo: Auston James. Our leaders come from—and work in—every part of the world. “We are delighted to have Steve bring his extensive global health and development expertise and insight to PATH,” said Dr. Molly Joel Coye, chair of PATH’s board of directors. He will join PATH on June 11 and be based at PATH’s Seattle headquarters. Steve Davis, CEO of PATH, talks about the need for the primary healthcare system to function in order to prevent major disease outbreak. These experiences have provided Mr. Davis with a deep understanding of the dynamics of the global development sphere and a strong foundation in the challenges for leadership in innovation, research and development, and advocacy. Mr. Davis succeeds former president and CEO Dr. Christopher J. Elias, who led PATH through significant growth for ten years and positioned the organization as an effective leader in global health.
The Hobbit: The Battle Of The Five Armies Subtitles, The Gray Man Movie 2020, Georgia Tech Basketball Stats, Xosha Roquemore Precious, How To Pronounce Nick, How Old Was Donna Reed When She Died, Sue Snell Musical, Berlinda Tolbert Net Worth 2018, Dazn Feltham Charge On Credit Card,